AKT |
Protein kinase B |
ALD |
Alcoholic liver disease |
AST |
Aspartate transaminase |
ATX |
Autotaxin |
AUROC |
Area under the receiver operating characteristic |
BMI |
Body mass index |
CCR |
C-C chemokine receptors |
CI |
Confidence interval |
ECM |
Extracellular matrix |
ER |
Endoplasmic reticulum |
ERK |
RAS extracellular signal-regulated kinase |
GCK |
Glucokinase regulator |
HCC |
Hepatocellular carcinoma |
HOMA |
Homeostasis model assessment parameter |
HR |
Hazard ratio |
HSC |
Hepatic stellate cell |
HSD17B13 |
Hydroxysteroid 17β-dehydrogenase |
IGF |
Insulin-like growth factor |
IGN |
Intestinal gluconeogenesis |
IKK |
Inhibitor of nuclear factor-κB kinase |
IL |
Interleukin |
IR |
Insulin resistance |
IRS |
Insulin receptor substrate |
JNK |
c-Jun N-terminal kinase |
JSG-NAFLD |
Japan Study Group of NAFLD |
LOXL2 |
Lysyl oxidase-like 2 |
LSM |
Liver stiffness measurement |
Mac-2bp |
Mac-2 binding protein |
MBOAT7 |
Membrane bound O-acyltransferase domain- containing 7 |
MMP |
Matrix metalloproteinase |
MRE |
Magnetic resonance elastography |
NAFLD |
Nonalcoholic fatty liver disease |
NASH |
Nonalcoholic steatohepatitis |
NF-κB |
Nuclear factor-kappa B |
NFS |
NAFLD fibrosis score |
OPN |
Osteopontin |
OR |
Odds ratio |
PDK |
Phosphoinositide-dependent kinase |
PI3K |
Phosphatidylinositol 3-kinase |
PNPLA3 |
Patatin-like phospholipase domain containing 3 |
SOCS |
Suppressor of cytokine signaling |
TAZ |
Transcriptional coactivator with PDZ- binding motif |
TEAD |
TAZ/TEA domain |
TGF-β |
Transforming growth factor-β |
T2DM |
Type2 diabetes mellitus |
TM6SF2 |
Transmembrane 6 superfamily member 2 |
TNF |
Tumor necrosis factor |
VCTE |
Vibration-controlled transient elastography |
WFA+-M2bp |
Wisteria floribunda agglutinin-positive Mac-2-binding protein |